메뉴 건너뛰기




Volumn 50, Issue 6, 2001, Pages 94-97

Impact of the 1999 AAP/USPHS joint statement on thimerosal in vaccines on infant hepatitis B vaccination practices
[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VACCINE; PRESERVATIVE; THIOMERSAL;

EID: 0035895920     PISSN: 01492195     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (25)

References (9)
  • 1
    • 0033538377 scopus 로고    scopus 로고
    • Thimerosal in vaccines: A joint statement of the American Academy of Pediatrics and the Public Health Service
    • CDC. Thimerosal in vaccines: a joint statement of the American Academy of Pediatrics and the Public Health Service. MMWR 1999;48:563-5.
    • (1999) MMWR , vol.48 , pp. 563-565
  • 2
    • 0005543506 scopus 로고    scopus 로고
    • Thimerosal in vaccines: An interim report to clinicians
    • American Academy of Pediatrics. Thimerosal in vaccines: an interim report to clinicians. AAP News 1999;15:10-2.
    • (1999) AAP News , vol.15 , pp. 10-12
  • 3
    • 0033543276 scopus 로고    scopus 로고
    • Availability of hepatitis B vaccine that does not contain thimerosal as a preservative
    • CDC. Availability of hepatitis B vaccine that does not contain thimerosal as a preservative. MMWR 1999;48:780-2.
    • (1999) MMWR , vol.48 , pp. 780-782
  • 4
    • 0008793292 scopus 로고
    • Hepatitis B virus: A comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination
    • Advisory Committee on Immunization Practices. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. MMWR 1991;40(no. RR-13).
    • (1991) MMWR , vol.40 , Issue.RR-13
  • 5
    • 0000897528 scopus 로고
    • Epidemiology of hepatocellular carcinoma
    • Vyas GN, Diestag JL, Hoofnagle JH, eds. New York: Grune & Stratton
    • Beasley RP, Hwang L-Y. Epidemiology of hepatocellular carcinoma. In: Vyas GN, Diestag JL, Hoofnagle JH, eds. Viral hepatitis and liver disease. New York: Grune & Stratton, 1984:209-24.
    • (1984) Viral Hepatitis and Liver Disease , pp. 209-224
    • Beasley, R.P.1    Hwang, L.-Y.2
  • 6
    • 0025892665 scopus 로고
    • Hepatitis B: Evolving epidemiology and implications for control
    • Margolis HS, Alter MJ, Hadler SC. Hepatitis B: evolving epidemiology and implications for control. Semin Liver Dis 1991;11:84-92.
    • (1991) Semin Liver Dis , vol.11 , pp. 84-92
    • Margolis, H.S.1    Alter, M.J.2    Hadler, S.C.3
  • 7
    • 0034706004 scopus 로고    scopus 로고
    • Association between administration of hepatitis B vaccine at birth and completion of the hepatitis B and 4:3:1:3 vaccine series
    • Yusuf HR, Daniels D, Smith P, Coronado V, Rodewald L. Association between administration of hepatitis B vaccine at birth and completion of the hepatitis B and 4:3:1:3 vaccine series. JAMA 2000;284:978.
    • (2000) JAMA , vol.284 , pp. 978
    • Yusuf, H.R.1    Daniels, D.2    Smith, P.3    Coronado, V.4    Rodewald, L.5
  • 8
    • 0002065089 scopus 로고    scopus 로고
    • Resume the hep B immunization at birth: AAP
    • Pickering LK. Resume the hep B immunization at birth: AAP. AAP News 2000;16:1,7.
    • (2000) AAP News , vol.16 , pp. 1
    • Pickering, L.K.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.